Summarv The matnrx metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are perceived as essential for tumour invasion and metastasis. In the present study. we compare the topographical pattern of MMP-9 and TIMP-1 expression in colorectal cancer and liver metastases bv in situ hvbridisation.
Matrix metalloproteinases (MMPs) are a famils of metaldependent endopeptidases with proteolytic activities for various components of the extracellular matrix (Liotta and Stetler-Stevenson. 1991 ; Ennis and Matrisian. 1994) . The MMP family comprises at least nine members (Woessner. 1994). All family members are secreted in a latent form that becomes active upon cleavage of a 10 000 dalton peptide (Ennis and Matrisian. 1994) . Since type IV collagen is a major component of basement membranes, the 72 kDa (MMP-2) and 92 kDa (MMP-9) type IV collagenases are of particular interest.
Over the last decade. much attention has focused on the role of MMPs in tumour invasion and metastases Stetler-Stevenson. 1991: Murphy et al.. 1989) . Both in vitro and in vivo data have indicated that MMPs participate. via accelerated breakdown of extracellular matrices. in tumour invasion and metastases (Liotta et al.. 1980 : Nakajima et al.. 1987 : Ura et al.. 1989 . Furthermore. increased production of MMP has been associated with increased invasive and metastatic potential in several human malignant tumours : Urbanski et al.. 1992 ; Boag and Young, 1993: Brown et al.. 1993) . Although. MMP-9 is secreted by a wide range of cells. including macrophages, neutrophils. capillary endothelial cells and trophoblasts. from both normal and malignant tissue (Hibbs et al.. 1985 1988: Werb and Alexander. 1993) in primary colorectal cancer. it appears that MMP-9 mRNA may be macrophage in origin (Pyke et al., 1993) .
MMP activity, in vivo. is thought to be regulated in part by natural tissue inhibitor proteins such as tissue inhibitors of metalloproteinases (TIMP) Stetler-Stevenson. 1991: Ennis and . Thus far. three TIMP genes (TIMP-1. TIMP-2 and TIMP-3) have been identified (Murphy et al.. 1981 : Stetler-Stevenson et al.. 1989 : Pavloff et al.. 1992 . TIMP (Guillem et al.. 1990 : Lu et al.. 1991 : Zeng et al.. 1995 . Recently. using Northern blot analysis of whole-tissue homogenates. we demonstrated a parallel overexpression of TIMP-1 and MMP-9 mRNA in colorectal cancer and liver metastases. suggesting co-regulation of these two genes (Zeng et al., 1993) . However. because of tissue cellular heterogeneity. the exact cellular origin of TIMP-1 and MMP-9 mRNA in colorectal cancer and liver metastases homogenates remained unclear. In the present study. in situ hybridisation analysis was used to investigate the cellular distribution of TIMP-1 and MMP-9 mRNA expression in human colorectal cancer and liver metastases.
Materials and methods
Tissue samples All surgical samples used in this study were randomly obtained from the operating room immediately after resec- (Feinberg and Vogelsteim, 1983 (Figure 1 ). The mean tumour,' normal (T/N) fold increases of TIMP-1 and MMP-9 in primary cancer were 9.1 ± 1.9 (P<0.01) and 12.9 ± 5.0 (P<0.01), while in liver metastases they were 11.1 ± 3.6 (P <0.05) and 3.47 ± 1.2 (P <0.05) respectively.
In situ hkbridisation of MMP-9 and TIMP-J mRNA in primary colorectal cancer As seen in Figure 2 , primary colorectal cancers show detec- In situ hybridisation analysis revealed a remarkably specific signal for MMP-9 (Figure 4 ) and TIMP-1 ( Figure 5 ) mRNA transcripts in all ten liver metastases from colorectal cancer.
No expression was detected in adjacent normal liver and hybridisations with MMP-9 and TIMP-1 sense probes were also negative (data not shown).
Distinct localisation of MMP-9 and TIMP-J expression Although both MMP-9 and TIMP-1 mRNA signals were strongest within stromal cells of tumours, the spatial distributions of MMP-9 and TIMP-1 mRNA were distinctlv different. In order to compare directly the spatial expression of MMP-9 and TIMP-1. we hybridised serial sections of the same samples. As seen in serial sections (Figure 2 ). MMP-9 mRNA hybridisation resulted in a more focused signal. strongest within a small population of stromal cells encircling the tumour epithelial cells (Figure 2b and c), whereas TIMP-1 mRNA hybridisation produced a diffuse scattering signal (Figure 2e and f). The general expression patterns of MMP-9 and TIMP-1 mRNA in liver metastases were similar to those in primarn colorectal cancers. Comparison of MMP-9 and TIMP-1 mRNA expression in liver metastases indicates that, although hybridisation signals for MMP-9 and TIMP-1 transcripts were clearly localised in tumour stroma, MMP-9 and TIMP-1 mRNA have distinctly different patterns of distribution. As seen in Figure 4a and b. large numbers of MMP-9-positive cells were localised at the interface between the liver metastases lesion (LM) and surrounding normal liver parenchyma (NL). However, TIMP-1 mRNA was found throughout malignant tumour stroma (Figure 5a and b) .
Higher magnifications of the area bordered by arrows in Figure 2b and e are shown in Figure 2c and f. The MMP-9 mRNA signals were seen in a small population of stromal cells encircling the tumour epithelial cells (Figure 2c To identify the cells expressing MMP-9 mRNA three colorectal cancer and two liver metastases samples were examined by immunohistochemical staining with the monoclonal antibody KPl (CD68). known to be macrophage specific (Pulford et al.. 1989) . positive for MMP-9 mRNA expression in liver metastases have a circular morphology ( Figure 6a ) and were identified as macrophages by immunostaining of adjacent sections with anti-macrophage antibody ( Figure 6b ). As noted, not all macrophages were positive for MMP-9 mRNA expression.
Discussion
Our present in situ hybridisation results are consistent with our prior Northern blot demonstration of MMP-9 and TIMP-1 mRNA overexpression in primary colorectal cancer and liver metastases (Zeng et al., 1993 the evidence that MMP-9 and TIMP-1 mRNA are predominantly stromal in origin in both primary colorectal cancer and liver metastases. To our knowledge, this is the first report demonstrating a distinct spatial expression of MMP-9 and TIMP-1 mRNA in liver metastases from colorectal cancers.
MMP-9 is produced in vitro by a variety of cell types, including fibroblasts, endothelial cells, keratinocytes, macrophages and chondrocytes (Werb and Alexander, 1993) . The synthesis of MMP-9 has been induced by SV-40 transformation of human fibroblasts (Wilhelm et al., 1989) . Under normal circumstances this enzyme is a major secretion product of tissue macrophages (Wilhelm et al., 1989) and has been found in the granules of polymorphonuclear leucocytes and in cultured keratinocytes (Wilhelm et al.,1989) . In human granuloma annulare and necrobiosis lipoidica diabeticorum, MMP-9 is expressed in eosinophils (Saarialho-Kere et al., 1993) . Our observation that MMP-9 mRNA may be produced by peritumour macrophages is consistent with a study (Pyke et al., 1993) in which MMP-9 was found in stroma cells of colorectal cancers. Similar to ,se@ .
1 . colon cancers, in situ hybridisation studies have shown MMP-9 mRNA to be localised in the stroma of breast (Davies et al., 1993a) and bladder cancers (Davies et al.. 1993b) . In human skin cancer, six of nine squamous cell carcinomas expressed MMP-9 mRNA (Pyke et al., 1992) . However, none of the basal cell carcinomas, a rarely metastatic tumour, expressed MMP-9 mRNA (Pyke et al., 1992) .
The role for several metalloproteinases in colorectal tumorigenesis is supported by Newell et al. (1994) who demonstrated matrilysin (MMP-7) expression in both benign and malignant colorectal tumour. However, the expression of stromelysin-(MMP-3), and MMP-2 was noted only in colorectal cancer. These findings suggest that MMP-7 expression is an early event and that MMP-3, MMP-l 1 and MMP-2 expression is b MMP-9 and TIMP-1 mRNA in colon cancer and mer me ms (Stricklin and Welgus, 1983) , chondrocytes (Gavrilovic et at., 1987) and endothelial (Herron et at., 1988) , and vascular smooth muscle cells (DeClerck, 1988 (Saarialho-Kere et al., 1993) , suggesting that fibroblasts may serve as a source for TIMP-1. Our in situ hybridisation data are consistent with a study by Hewitt et al. (1991) which demonstrated increased protein expression of collagenase and TIMP-1 in colorectal cancers compared with adenomas and normal mucosa. The strongest immunohistochemical collagenase and TIMP signals were noted close to islands of neoplastic cells. Furthermore, in this study, the staining intensity in the invasive edge increased for collagenase but decreased for TIMP (Hewitt et al., 1991) .
Parallel overexpression of TIMP-1 and MMP-9 mRNA noted in primary colorectal cancer and liver metastases homogenates (Zeng et al., 1993) suggests possible coregulation of these two important genes in vivo. Although the expression of several MMPs (MMP-2,-3,-7,-9 and -II) is elevated in colorectal cancer (Newell et al., 1994) , the distinct pattern of cellular TIMP-1 and MMP-9 expression noted by in situ hybridisation suggests that elevated TIMP-1 expression may not be simply a response to local increases in MMP-9 expression. This notion is supported by the fact that TIMP-1 has growth-promoting properties (Gasson et al., 1985; Avalos et al., 1988; Bertaux et al., 1991) . Hayakawa et al. (1992) have found that TIMP-1 accounts for a significant portion of the growth factor activity of serum and is capable of stimulating a wide range of human and bovine cell lines, including those derived from tumours (human breast adenocarcinoma, erythroleukaemia, myelogenous leukaemia and Burkitt's lymphoma). These data, along with the recent observation that TIMP-1 stimulates the secretion of collagenase from human skin fibroblasts (Clark et al., 1994) , suggest that, in addition to its role as a metalloproteinase inhibitor, TIMP-1 may also function as a growth factor in the pathogenesis of a variety of diseases. The mechanism of TIMPs' multiple function is presently unknown. However, it is postulated that the domains responsible for growth factor activity are physically distinct from those responsible for regulating metalloproteinase activity (Docherty et al., 1992; Stetler-Stevenson et al., 1992) .
In conclusion in situ hybnrdisation analysis has shown distinct patterns of TIMP-1 and MMP-9 mRNA expression in both primary colorectal cancer and liver metastases. Our results demonstrate that MMP-9 and TIMP-1 mRNA are produced not by colorectal cancer cells themselves, but rather by surrounding macrophages and fibroblast-like cells respectively. In addition, the distinct, non-juxtaposed pattern of MMP-9 and TIMP-1 expression suggests that TIMP-1 may not be produced simply in response to local elevations of and suggests that in vivo these genes are independently regulated. Further studies are needed to define the colorectal cancer-stroma cell interactions involved in the regulation of MMPs and TIMP productions.
